Cohance Lifesciences receives ESG rating from Crisil
Cohance Lifesciences receives ESG rating from Crisil. Crisil ESG Ratings & Analytics Limited has assigned an ESG score to Cohance Lifesciences Limited. The rating reflects the company’s environmental, social, and governance practices. This development may interest long-term investors focused on sustainable investing.
📊 STOCKS: $COHANCELIFE | 🏢 SECTOR: Pharma | #LOWIMPACT #ESG
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.